GNFT NIS2+ set to transform MASH diagnostics and patient monitoring
TradingView News says GNFT’s NIS2+ is positioned as a scalable, non-invasive solution for MASH diagnostics, validated by independent studies, aimed at enabling patient identification and monitoring.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.